Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-11-02

Clinical Trial Update: Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients [NA]

View source ↗

Summary

A clinical trial update examining the effects of micronized trans-resveratrol in Polycystic Ovary Syndrome; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Micronized Trans-resveratrol (trans-resveratrol)

Snippet

Sponsor: Poznan University of Medical Sciences | Conditions: Polycystic Ovary Syndrome (PCOS) | NA | Status: UNKNOWN